New inserts in cigarette packs to help smokers quit?

UK Government seeks views on adding pack inserts to tobacco products to encourage smokers to quit

  • Pack inserts are used internationally including in Canada and Israel, and proven to encourage people to give up smoking
  • Initial report on the Major Conditions Strategy to be published today

The UK government will seek views on adding pack inserts into tobacco products to encourage more smokers to quit as it launches a new consultation today.

Placed inside the packaging of cigarettes and hand rolling tobacco, they would contain positive messages to encourage people to quit and signpost them to advice and support.

The messages set out the health benefits of quitting – for example, improvements to breathing within a matter of days and a 50% reduction in the risk of heart attack within a year – as well as showing smokers how much money they stand to save by giving up, with the average person likely to save over £2,000 per year if they quit.

Smoking remains the single leading preventable cause of illness and mortality in the UK. It results in nearly 4% of all hospital admissions each year – equivalent to almost 450,000 admissions. Tobacco-related harms are also estimated to cost taxpayers an estimated £21 billion every year, including over £2 billion in costs to the NHS.

Although smoking rates in the UK are at an all-time low, by taking further action, the government will seek to cut waiting lists and reduce the burden on the NHS. Introducing pack inserts into all tobacco products in the UK could lead to an additional 30,000 smokers giving up their habit – delivering health benefits worth £1.6 billion.

Health and Social Care Secretary Steve Barclay said: “Smoking places a huge burden on the NHS, economy and individuals. It directly causes a whole host of health problems – including cancers and cardiovascular disease – and costs the economy billions every year in lost productivity.

By taking action to reduce smoking rates and pursuing our ambition to be smokefree by 2030, we will reduce the pressure on the NHS and help people to live healthier lives.”

The consultation – which opens today – will seek views on the introduction and design of pack inserts.

Pack inserts are already used in other countries – including Canada and Israel, with Australia also announcing its intention to introduce them – and there is evidence that they can be an effective means of encouraging smokers to quit.

An evaluation of the policy’s impact in Canada found that almost 1 in 3 smokers had read the inserts at least once in the past month, and that those who were exposed to the inserts multiple times were significantly more likely to try to give up smoking.

The consultation builds on a recent package of measures designed to drive the government’s ambition to be smokefree by 2030 – which means reducing smoking rates to 5% or less.

These measures include:

  • Funding a new national ‘swap to stop’ scheme – the first of its kind in the world – to offer a million smokers across England a free vaping starter kit, alongside expert support
  • Launching a financial incentive scheme – in the form of vouchers alongside behavioural support – to support pregnant women to stop smoking, with an aim to reach all pregnant smokers by the end of next year
  • A new strategy to combat illicit tobacco, which will outline efforts to catch and punish those involved in the illegal market

Deborah Arnott, chief executive of Action on Smoking and Health (ASH), said: “Smoking is very addictive, and it takes smokers on average thirty attempts before they succeed in stopping, so encouraging them to keep on trying is vital.

“Pack inserts do this by backing up the grim messages about death and disease on the outside with the best advice about how to quit on the inside.

“They will help deliver not just the Smokefree 2030 ambition, but also the Major Conditions Strategy, as smoking is responsible for all six major conditions from cancer to cardiovascular and respiratory disease, as well as dementia, mental ill health and musculoskeletal disorders.”

The consultation launch comes as the government publishes an initial report on its Major Conditions Strategy – which covers the six groups of conditions accounting for 60% of all ill-health and early death in England.

One in four people in England live with two or more major long-term conditions, and the initial report sets out the direction for the strategy to tackle these groups of conditions – cancers, cardiovascular diseases (including stroke and diabetes), musculoskeletal disorders, mental ill health, dementia and chronic respiratory conditions.

This includes by addressing key risk factors and lifestyle drivers of ill-health and disease, including smoking, which is a direct contributor to all six groups of conditions covered by the strategy. For example, it is the biggest cause of cancer, with one in every five cancer deaths in England connected to smoking.

A world leader in reducing smoking rates, UK levels are currently at their lowest on record at 13.3%. But across the UK, 1 in 7 adults still smoke – around 6.6 million people – and the impacts on the NHS and economy are significant.

Tobacco also costs the economy in England an estimated £14 billion in lost productivity every year, due to lost earnings, unemployment and early deaths. The average smoker stands to save approximately £2,000 per year from giving up their habit.

UK Health Secretary offers waiting list support to Wales and Scotland

The UK Health and Social Care Secretary has invited the devolved administration for talks to discuss lessons learnt and tackle waiting lists across the UK

The UK Government Health and Social Care Secretary Steve Barclay has written to the devolved administrations inviting them for talks about how all parts of the UK can work together to tackle long-term waiting lists in all parts of the UK.

NHS services across the UK are a devolved matter, but Prime Minister Rishi Sunak has made cutting waiting lists a priority across the UK. Although approaches taken across England, Scotland, Wales and Northern Ireland share many common features, significant variations in outcomes exist.

In Wales, more than 73,000 people are waiting over 77 weeks for treatment, and at least 21,600 people are waiting over 78 weeks for an outpatient, day case or inpatient appointment in Scotland. In England, waiting times for patients over 78 weeks have been virtually eliminated.

The Secretary of State is inviting health ministers from the devolved administrations to discuss what lessons can be learnt from the different approaches taken.

In England for example, NHS patients are offered a choice of provider at GP referral – NHS or independent sector – provided that it meets NHS costs and standards. And from October we will proactively notify patients waiting over 40 weeks for treatment of their right to choose to be treated elsewhere.

In his letter, the Secretary of State writes that he would be open to requests from the devolved administrations to allow patients in Wales and Scotland who are waiting for lengthy periods to choose to be treated at providers in England, NHS or independent sector – building on the current arrangements for cross-border healthcare.

The Secretary of State has also asked UK health ministers to discuss how health data can be made more comparable across the UK. Northern Ireland official counterparts have also been invited to the ministerial meeting.

Health and Social Care Secretary Steve Barclay said: “I hugely value being able to share knowledge and experiences on the joint challenges facing our healthcare systems. I want to support collaboration between our nations to share best practices, improve transparency and provide better accountability for patients.

“This will help to ensure we are joined up when it comes to cutting waiting lists – one of the government’s top five priorities – and will allow us to better work together to improve performance and get patients seen more quickly.”

The letter reads:

Dear Michael and Eluned,

Thank you for a constructive meeting last month.

As you know, the NHS is at the forefront of people’s minds, and the Prime Minister has made cutting waiting lists a priority to ensure people across the UK get the care they need more quickly. We must continue to take steps to support the NHS and reduce waiting times to ensure no part of the UK is left behind. I am therefore concerned by the variation in performance across NHS services.

As we look to address this issue, it is important that the UK Government and Devolved Administrations work together to ensure that no matter where you are in the country, citizens can access vital services quickly.

In England, we are delivering on the actions set out in the NHS’s Elective Recovery Implementation Plan published last February. Our target to virtually eliminate waits of longer than two years by July 2022 was achieved on time and waits for treatment of more than 78 weeks have been virtually eliminated. Although data is not collected on the same basis across the UK, recent figures show more than 73,000 people are waiting over 77 weeks for treatment in Wales, and at least 21,600 people are waiting over 78 weeks for an outpatient, daycase or inpatient appointment in Scotland.

Whilst there are common features across the approaches of England, Wales and Scotland, one area of difference relates to patient choice. In England, patients have the legal right to choose the provider for their first outpatient appointment (at the point of GP referral) for many healthcare services. Patients may choose to be treated free of charge at any provider – NHS or independent sector – provided they meet NHS standards and costs and hold a contract for the provision of services to the NHS. A Patients Association study has found that this can reduce a patient’s waiting time by up to 3 months.

From October, we will proactively notify patients in England who have been waiting over 40 weeks of their right to request to be treated at a different provider if clinically appropriate, again in the NHS or in the independent sector, provided they meet NHS standards and costs, and they hold a contract for the provision of services to the NHS.

The Secretaries of State for Scotland and Wales share my desire to see patients across the UK have the same rights when it comes to accessing treatment. I would therefore be happy to facilitate a Ministerial working group session (with NI official counterparts) to share how we are implementing this choice approach in England, and to share lessons on work across the UK to tackle the elective waiting list. I would also be open to considering any request from you for patients waiting for lengthy periods for treatment in Scotland and Wales to be able to choose from alternate providers in England – NHS or independent sector – in line with the approach we are taking here, and building on the existing arrangements for cross-border healthcare.

I also believe we need to work together to ensure that health data is more comparable across the UK. It is important that all our citizens can understand the performance of the health services they are receiving and that we can learn from what has been tried and tested in one part of the UK to improve services across the country. I welcome the work our respective teams have been doing to improve data comparability, for example through the Office for National Statistics’ work to improve key UK-wide health performance metrics.

I am very keen to see this work progress and ask for your continued support in prioritising this moving forward.

In the absence of Ministers in Northern Ireland, I am copying this letter to the Department of Health in Northern Ireland and the Secretary of State for Northern Ireland.

Yours sincerely,

RT HON STEVE BARCLAY MP

COVID-19 testing guidance update

Testing to be based on clinical need in hospitals, care homes and prisons

Routine COVID-19 testing in hospitals, care homes and prisons is to be substantially reduced following clinical and scientific advice.

Due to the success of the vaccination programme and improved treatments, Public Health Scotland and Antimicrobial Resistance & Healthcare Associated Infection Scotland have recommended a return to pre-pandemic testing.

This means testing will be based on person-centred clinical decisions, rather than a routine policy for all individuals. Routine testing will continue for patients moving from hospitals to care homes and will be reviewed based on future advice and outbreaks. Tests will also continue to be available for those eligible for antiviral treatment.

The new guidance will come into effect by 30 August 2023.

Chief Medical Officer Professor Sir Gregor Smith said: “Due to the success of vaccines in protecting people, and the availability of improved treatments, now is the right time to revise the advice on routine COVID-19 testing across health and social care settings and prisons. This will ensure the testing regime remains effective and proportionate.

“Routine testing will remain when patients are discharged from hospital to care homes, to provide additional reassurance for these settings, and testing will still be required when clinically appropriate.

“The clinical advice tells us that focusing on the risk to individuals under general infection control procedures will allow our hospital, social care and prison staff to better protect those in their care and that there is no longer a requirement to apply separate COVID-19 guidance across the board when so many are now protected from its worst harms.”

COVID CASES ON THE RISE

This UK Health Security Agency fortnightly flu and COVID-19 report brings together the latest surveillance data along with the latest public health advice.

The latest report was produced on 3 August:

COVID-19 case rates continued to increase this week compared to our previous report. 5.4% of 4,396 respiratory specimens reported through the Respiratory DataMart System were identified as COVID-19. This is compared to 3.7% of 4,403 from the previous report.

The overall COVID-19 hospital admission rate for week 30 was 1.97 per 100,000 population, an increase from 1.17 per 100,000 in the previous report.

ICU admission rates have decreased to 0.05 compared to 0.07 in the previous report.

Those aged 85 years and over continue to have the highest hospital admission rates; these have increased to 20.49 per 100,000 from 9.8 per 100,000 in the previous report.

Admission rates among those aged 75 to 84 years have increased to 9.45 per 100,000 from 5.54 in the previous report.

Dr Mary Ramsay, Head of Immunisation at the UK Health Security Agency (UKHSA), said: “We continue to see a rise in COVID-19 cases in this week’s report. We have also seen a small rise in hospital admission rates in most age groups, particularly among the elderly.

“Overall levels of admission still remain extremely low and we are not currently seeing a similar increase in ICU admissions. We will continue to monitor these rates closely.Regular and thorough hand washing helps protect you from COVID-19 and other bugs and viruses.

“If you have symptoms of a respiratory illness, we recommend staying away from others where possible.

“The NHS will be in contact in autumn 2023 when the seasonal vaccine is available for those who are eligible due to health conditions or age, and we urge everyone who is offered to take up the vaccine when offered.”

Life and Death: MSP calls for a defibrillators to be installed at train stations across Lothian

Scottish Conservative and Unionist MSP for Lothian Miles Briggs is calling for a defibrillator to be installed at every train station in Lothian.

Mr. Briggs’ call comes following a response received by Scottish Conservative MSP Jamie Greene from former SNP transport minister Kevin Stewart.

The Transport Minister’s response highlighted the 56 Scottish train stations that are currently equipped with a defibrillator, including some of the country’s busiest such as Central and Queen Street in Glasgow and Edinburgh Waverley.

Kevin Stewart also confirmed to Jamie Greene that plans to install further defibrillator devices across the ScotRail network are being developed.

However, with Scotland having 359 railway stations in total, Miles Briggs says it is crucial that more passengers and staff are able to access defibrillators as soon as possible.

He says having quick and easy access to the device on site at busy stations such as Livingston North could help to save lives in an emergency.

At present, the train stations in Lothian without access to a defibrillator are: Drem, Dunbar, Haddington, Longniddry, Musselburgh, North Berwiick, Prestonpans, Wallyford, Eskbank, Gorebridge, Shawfair, Wallyford, Addiewell, Armadale, Blackridge, Breich, Fauldhouse, Kirknewton, Livingston North, Uphall and West Calder.

Mr. Briggs added that he hopes that people across Scotland will get behind the campaign and ensure that stations across the country are fitted with defibrillators.

Scottish Conservative and Unionist MSP Miles Briggs said: “Having easy access to a defibrillator device can often be the difference between life and death.

“While it is welcome that over 50 stations in Scotland now have them on site, this is only the beginning. It is imperative that we do what we can to ensure that stations across the country have access to a defibrillator.

“You never know when a defibrillator might be required, and the eventual goal should be to ensure that every station in Scotland can get one.

“An emergency situation might arise at any moment, so having a defibrillator on hand to use before emergency services arrive, would be of great help.

“In my region of Lothian, we have busy stations such as Livingston North and North Berwick that are without defibrillators. I believe it is common sense for devices to be installed in these areas.

“As it stands, it is not good enough that only 6 railways stations across Lothian have access to a defibrillator.

“I will continue to encourage SNP ministers to guarantee ScotRail will have the resources they need to rollout further defibrillator devices, including hopefully at each Lothian station in the near future.”

Legionella bacteria at Western General: Investigations underway

Investigations are being carried out at the Western General Hospital following detection of Legionella bacteria in water supplying parts of the radiotherapy treatment area.

The source has been isolated and there have been no cases of infection in patients or staff.  The type of Legionella detected does not usually cause infection in humans. 

In line with national guidance, a thorough programme of disinfection and cleaning is being carried out and services temporarily relocated to minimise any potential risk.

Essential patient services are continuing to be provided in other areas of the building.

Two specialist radiotherapy treatment machines (Linacs) have been temporarily closed while remedial works continue. Patients who are normally treated on these Linacs will be reallocated to one of the other five treatment machines at the Western General Hospital which are not affected.

The remaining radiotherapy machines will be run for extended hours to ensure patient appointments continue to be allocated and carried out as quickly as possible.

Alison MacDonald, Nurse Director, NHS Lothian said: “Legionella bacteria was detected during routine water sampling as part of our building monitoring and hygiene vigilance measures.”

“The risk to patients and staff is low but we’ve enhanced infection and control measures across the building as a precaution. 

“We assure patients that radiotherapy treatments will continue to be carried out as quickly as possible and apologise to anyone who has been affected or had their appointment rescheduled.”

The situation is being closely monitored and continuously assessed. Patients will be kept informed of any changes and should speak to their treatment team if they have any concerns.

Record medical trainee recruitment levels in Scotland

New starts will begin training this August

More medical training posts have been accepted at this stage of the recruitment year than ever before – exceeding last year’s record by 100 posts.

NHS Education for Scotland data as of 25 July 2023 shows that 1,061 posts have been filled so far this year from 1,137 advertised.

This includes 100% fill rates at entry level in General Practice, Psychiatry, Anaesthetics, Radiology and Emergency Medicine.

These trainee doctors will take up post in August 2023. Another recruitment round will be held before the end of the year for those taking up post in February 2024.

Minister for Public Health Jenni Minto said: “I am delighted to see that Scotland continues to be recognised as a highly desirable place both to live and pursue a career in medicine.

“This is testament to our world-class medical education and training system as well as those working hard to prepare the next generation of doctors who will look after us in the future. 

“These results show that NHS Scotland continues to grow accordingly to meet the needs of its patients and I look forward to welcoming these new doctors into the health service.”

NHS Education for Scotland Medical Director Dr Emma Watson said: “As of today, 93% of posts advertised for August 2023 start dates in Scotland are filled.

“Many programmes have filled at 100% and in programmes which have not filled, we are working to understand why. There has also been a significant expansion of training posts across Scotland, particularly in General Practice which has a current fill rate of 100%.”

NHS highlights importance of measles vaccination to safeguard public health

NHSGGC has emphasised the importance of being vaccinated against measles, mumps and rubella following an increase in cases across the UK and Europe.

Measles is one of the most highly infectious diseases and can lead to serious and potentially life-threatening complications if it is not treated. Symptoms of measles include a high fever, rash, cough, runny nose and watery eyes. In the most severe of cases, measles can develop into more threatening conditions such as pneumonia, especially in those with a weakened immune system.

To combat this, NHSGGC strongly recommends members of the public are up to date with their vaccines to ensure protection against the disease. The normal course is two doses of MMR vaccine in childhood. It can also be given to adults, and if you have missed a dose, for whatever reason, you remain eligible and your GP can refer you in to one of the health board’s vaccine clinics.

The immunisation is provided from the health board free of charge and can be administered at a range of healthcare facilities across the city and at other locations in the NHSGGC area.

Iain Kennedy, Consultant in Public Health Medicine, said: “Getting vaccinated against measles helps prevent the spread of the disease and by increasing vaccination coverage, we can create a shield of immunity that safeguards individuals and the wider community.

“As we have noticed an increase in cases across the UK, it is important to ensure the safety of each other and in particular, young children.

“Measles can spread easily and quickly though droplets from the nose and mouth when an infected person coughs or sneezes.

“We would encourage all parents to ensure their child has had two doses of the MMR vaccine before they start school to help reduce the spread of infection.

“The best way to stay safe and healthy is to get vaccinated against the disease and collectively reduce the risks of outbreaks.”

For more information on measles and how you can stay protected, please visit NHS Inform.

Linda Bauld receives Honorary Degree from Robert Gordon University

Professor Linda Bauld OBE, who has been at the forefront of public health research in Scotland for the best part of 30 years, has been awarded an Honorary Degree from Robert Gordon University (RGU).

During RGU’s graduation ceremony at P&J Live in Aberdeen on Thursday 6 July, Professor Bauld was awarded a Doctor of Science (DSc) in recognition of her extensive research within public health, particularly in alcohol use and smoking cessation. 

The University acknowledges Professor Bauld’s continued work on the Covid-19 pandemic as the Scottish Government’s Chief Social Policy Adviser.

Professor Steve Olivier, Principal and Vice-Chancellor of RGU, said: “Professor Bauld has made an immense contribution to helping improve public health with her crucial research which has an impact on all our lives.

“This work is continuing with her role as an advisor to the Scottish Government as we continue to adapt and recover from the Covid-19 pandemic.

“It is a real honour for the University to be able to recognise a scientist whose inspiring research career is dedicated to finding ways to make us all live happier and healthier by tackling major issues such as cancer, diabetes, and smoking.”

Professor Bauld is a familiar face to many people as she regularly appeared on television during the pandemic using her scientific knowledge to communicate with the public through numerous media appearances to help us all make sense of the latest developments during the pandemic.

The Bruce and John Usher Chair in Public Health in the Usher Institute, College of Medicine at the University of Edinburgh, she is a behavioural scientist who research looks at two main areas, the evaluation of complex interventions to improve health, and how research can inform public health policy.

She has undertaken many major advisory roles for government and worked with charities as part of efforts to keep public health at the forefront of the minds of policy makers.

Professor Bauld was scientific adviser on tobacco control to the UK government between 2006 and 2010; Cancer Research UK’s cancer prevention champion from July 2014 to July 2021; and adviser to the Covid-19 committee of the Scottish parliament. 

She is a Fellow of the Royal College of Physicians of Edinburgh, the Academy of Social Sciences, the Royal Society of Edinburgh, and the Faculty of Public Health; and was awarded an OBE in the 2021 Queens Birthday Honours.

£28.3 million delayed discharge price tag in NHS Lothian

BOYACK: ‘Delayed discharge is piling pressure on our hospitals’

Scottish Labour MSP Sarah Boyack has warned that delayed discharge in Lothian is “piling pressure on hospitals” as a new report reveals the issue cost NHS Lothian more that £28million in 2022/23.

Delayed discharge figures monitor the number of days patients spend in hospital despite being fit to leave, typically because of a lack of social care services in their area.

Over the course of the year, a total of 97,118 bed days in NHS Lothian were lost to delayed discharge, as rates across Scotland hit a record high.

This includes 70,208 bed days in the City of Edinburgh.

Analysis by Scottish Labour has revealed that the approximate cost of delayed discharge to NHS Lothian in 2022/23 was an eye-watering £28,368,168.

Scottish Labour MSP Sarah Boyack said: “Delayed discharge in Edinburgh is piling pressure on our hospitals and threatening patients’ recovery.

“Our NHS is at breaking point and every penny matters, and it is a scandal that NHS Lothian has been forced to foot a £28million bill for SNP incompetence.

“Social care in Edinburgh and the Lothian is crying out for help, but the SNP’s botched National Care Service plans will do nothing but centralise local services.

“It is high time for the Scottish Government to step up and provide unwavering support for our social care services and increase pay for the sector’s dedicated workers, so no-one is left languishing in hospital waiting for a care package.”

Delayed discharge 2022/23 – Health Board

Delayed discharge bed days (age 18+) Estimated cost   
Scotland        661,705£193,284,031
NHS Ayrshire & Arran          70,677£20,644,752
NHS Borders          23,079£6,741,376
NHS Dumfries & Galloway          35,692£10,425,633
NHS Fife          40,379£11,794,706
NHS Forth Valley          41,946£12,252,427
NHS Grampian          40,413£11,804,637
NHS Greater Glasgow & Clyde        132,862£38,808,990
NHS Highland          50,566£14,770,329
NHS Lanarkshire          67,388£19,684,035
NHS Lothian          97,118£28,368,168
NHS Orkney            2,312£675,335
NHS Shetland            2,054£599,973
NHS Tayside          52,316£15,281,504
NHS Western Isles            4,903£1,432,166

Delayed discharge 2022/23 – Local Authority

Delayed discharge bed days (age 18+) 
Scotland661,705
Aberdeen City8,945
Aberdeenshire16,832
Angus6,407
Argyll & Bute11,944
City of Edinburgh70,208
Clackmannanshire4,983
Comhairle nan Eilean Siar5,185
Dumfries & Galloway35,511
Dundee City20,286
East Ayrshire9,943
East Dunbartonshire7,607
East Lothian3,251
East Renfrewshire4,652
Falkirk25,500
Fife43,363
Glasgow City74,875
Highland44,897
Inverclyde5,241
Midlothian9,377
Moray14,123
North Ayrshire22,316
North Lanarkshire37,801
Orkney2,427
Perth & Kinross23,700
Renfrewshire7,006
Scottish Borders23,406
Shetland2,142
South Ayrshire40,432
South Lanarkshire41,970
Stirling9,803
West Dunbartonshire13,905
West Lothian13,102

Source: https://publichealthscotland.scot/publications/delayed-discharges-in-nhsscotland-annual/delayed-discharges-in-nhsscotland-annual-annual-summary-of-occupied-bed-days-and-census-figures-data-to-march-2023/
 

Cost per bed day is estimated at £292.10 by adjusting the most recent estimated cost for inflation using the SPICe real terms calculator.   

Minimum Unit Pricing has ‘positive impact’ on health

Report concludes policy has saved lives and cut hospital admissions

Public Health Scotland (PHS) has today published the final report on the independent evaluation of the impact of minimum unit pricing (MUP) for alcohol in Scotland. Evidence shows that MUP has had a positive impact on health outcomes, including addressing alcohol-related health inequalities.

It has reduced deaths directly caused by alcohol consumption by an estimated 13.4% and hospital admissions by 4.1%, with the largest reductions seen in men and those living in the 40% most deprived areas.

MUP led to a 3% reduction in alcohol consumption at a population level, as measured by retail sales. The reduction was particularly driven by sales of cider and spirits through the off-trade (supermarkets and shops) products that increased the most in price. Evidence from a range of data sources shows that the greatest reductions were amongst those households purchasing the most alcohol, with little impact on households purchasing at lower levels.

For those people with alcohol dependence there was limited evidence of any reduction in consumption and there is some evidence of consequences for those with established alcohol dependence on low incomes, that led them to prioritise spending on alcohol over food. At a population level there is no clear evidence of substantial negative impacts on social harms such as alcohol-related crime or illicit drug use.

The evaluation report shows that while the impact on alcoholic drink producers and retailers varied depending on the mix of products made or sold, there is no clear evidence of substantial negative impacts on the alcoholic drinks industry in Scotland as a whole.

Clare Beeston, Lead for the evaluation of MUP, Public Health Scotland said: “We have seen reductions in deaths and hospital admissions directly caused by sustained, high levels of alcohol consumption, and this is further evidence that those drinking at harmful and hazardous levels have reduced their consumption.

“MUP alone is not enough to address the specific and complex needs of those with alcohol dependence who will often prioritise alcohol over other needs, and it is important to continue to provide services and any wider support that addresses the root cause of their dependence.

“Those living in the most socioeconomically deprived areas in Scotland experience alcohol-specific death rates at least five times greater than those living in the least deprived areas. Alcohol-related disorders are a leading contributor to health inequalities in Scotland.

“Overall, the evidence shows that MUP has had a positive impact on improving health outcomes, including alcohol-related health inequalities, and can play a part in addressing the preventable harm that affect far too many people, families and communities.”

Dr Nick Phin, Director of Public Health Science, Public Health Scotland said: “Public Health Scotland is committed to evidence-informed policy, and we are confident in the validity of the robust research published today. The evidence in our report is consistent with earlier research on minimum pricing elsewhere.

“Public Health Scotland is confident that MUP is an effective mechanism to reduce alcohol-related harm in Scotland and we support the continuation of MUP beyond April 2024.”

View the ‘Evaluating the impact of Minimum Unit Pricing for alcohol in Scotland’ report

Drugs and Alcohol Policy Minister Elena Whitham has welcomed research from Public Health Scotland which concludes that Minimum Unit Pricing (MUP) has saved lives, reduced hospital admissions and had a ‘positive impact’ on health.

In their final report of a series, researchers said that ‘robust, independent evaluation’ and the best-available, wide-ranging evidence drawing on 40 independent research publications, showed that MUP has been effective in its main goal of reducing alcohol harm with the reduction in deaths and hospital admissions specific to the timing of MUP implementation.

This follows a study published in March by PHS and University of Glasgow showing MUP reduced alcohol consumption by 3%, deaths directly caused by alcohol consumption by 13.4% and hospital admissions by 4.1%. compared to what would have happened if MUP had not been in place.

Ms Whitham said: ““We’re determined to do all we can to reduce alcohol-related harm and, as this research demonstrates, our world-leading policy is saving lives, reducing alcohol harms and hospital admissions. Just one life lost to alcohol-related harm is one too many and my sympathy goes to all those who have lost a loved one.

“MUP has also contributed to reducing health inequalities. The study found the largest reductions in deaths and hospital admissions wholly attributable to alcohol consumption were seen in men and those living in the 40% most deprived areas.

“We know that additional support is needed for some groups, including those dealing with alcohol dependence and issues such as homelessness. That’s why, alongside MUP, last year £106.8 million was made available to Alcohol and Drugs Partnerships to support local and national initiatives. We will now carefully consider this research as part of ongoing work on reviewing MUP.”